We demonstrated that over-expression of ISG15 is associated with improved ovarian cancer patient survival, and overexpression of ISG15 suppressed ovarian cancer growth and increased ovarian cancer apoptosis. This evidence concerns the gene ISG15 and ovarian cancer.